Clinical Trials Browser

Phase 2/3 × Tablets × 90 days × Clear all

NCT05316467 2026-06-04

Weight Management Plus Megestrol Acetate in Early-stage Endometrioid Carcinoma

Phase 2/3 Terminated

GynecologicOther

Infertility, Obesity, Endometrial Neoplasms, Overweight

NCT07504198 2026-03-31

Neuroprotection of Memantine and Rosuvastatin

Phase 2/3 Not yet recruiting

Peripheral Nervous System Diseases